We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPO
2326
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$123K ﹤0.01%
5,851
ALLK
2327
DELISTED
Allakos
ALLK
$123K ﹤0.01%
12,558
ANNX icon
2328
Annexon
ANNX
$873M
$123K ﹤0.01%
10,674
OIS icon
2329
Oil States International
OIS
$536M
$123K ﹤0.01%
24,658
RBB icon
2330
RBB Bancorp
RBB
$462M
$123K ﹤0.01%
4,676
-3,153
-40% -$80.6K
DJCO icon
2331
Daily Journal
DJCO
$767M
$122K ﹤0.01%
342
VKTX icon
2332
Viking Therapeutics
VKTX
$3.97B
$122K ﹤0.01%
26,477
+11,454
+76% +$64.2K
STXS icon
2333
Stereotaxis
STXS
$139M
$121K ﹤0.01%
19,595
+14,312
+271% +$85.5K
MAX icon
2334
MediaAlpha
MAX
$787M
$121K ﹤0.01%
7,846
LCTX icon
2335
Lineage Cell Therapeutics
LCTX
$278M
$121K ﹤0.01%
49,379
+32,752
+197% +$76.7K
FPI
2336
Farmland Partners
FPI
$425M
$121K ﹤0.01%
10,095
+5,999
+146% +$71.5K
CNTY icon
2337
Century Casinos
CNTY
$34.3M
$121K ﹤0.01%
9,899
+5,931
+149% +$83.4K
ICVX
2338
DELISTED
Icosavax, Inc. Common Stock
ICVX
$120K ﹤0.01%
5,257
KRUS icon
2339
Kura Sushi USA
KRUS
$637M
$120K ﹤0.01%
+1,484
New +$86.9K
KRO icon
2340
KRONOS Worldwide
KRO
$905M
$120K ﹤0.01%
7,992
AMTI
2341
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$120K ﹤0.01%
8,573
INFU icon
2342
InfuSystem Holdings
INFU
$244M
$119K ﹤0.01%
6,986
AMTX icon
2343
Aemetis
AMTX
$126M
$119K ﹤0.01%
9,652
CLVS
2344
DELISTED
Clovis Oncology, Inc.
CLVS
$119K ﹤0.01%
43,789
+23,024
+111% +$85.1K
RES icon
2345
RPC Inc
RES
$1.4B
$118K ﹤0.01%
26,045
ORC
2346
Orchid Island Capital
ORC
$1.32B
$118K ﹤0.01%
5,249
-3,484
-40% -$83.5K
FNLC icon
2347
First Bancorp
FNLC
$402M
$118K ﹤0.01%
3,758
AMSC icon
2348
American Superconductor
AMSC
$1.56B
$118K ﹤0.01%
10,830
RNAC icon
2349
Cartesian Therapeutics
RNAC
$262M
$118K ﹤0.01%
1,203
+654
+119% +$70.4K
AOUT icon
2350
American Outdoor Brands
AOUT
$159M
$117K ﹤0.01%
5,891

Similar funds

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.